Inhibition of immediate hypersensitivity reactions in the rat by ICI 74,917 and disodium cromoglycate.
ICI 74,917, a potent inhibitor of IgE-mediated passive cutaneous anaphylaxis (PCA) in the rat, exhibited tachyphylaxis in that pre-dosing sensitised rats with a high dose of compound reduced the inhibitory effect on rat PCA of a second dose given at challenge. This phenomenon was most apparent when the pre-dose-challenge dose interval was 15--60 min. Similar findings were obtained using antigen-induced histamine release in vitro from rat peritoneal cells. In these respects, ICI 74,917 was similar to disodium cromoglycate (DSCG) although DSCG appeared less effective in inducing tachyphylaxis than ICI 74,917. There was no evidence in vivo or in vitro that a high dose of either DSCG or ICI 74,917 enhanced the activity of a second low dose of either drug given at challenge.
D000818:Animals; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D003429:Cross Reactions; D006636:Histamine Release; D006969:Hypersensitivity, Immediate / Q000517:prevention & control*; D008407:Mast Cells / Q000276:immunology; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects; D010618:Phenanthrolines / Q000627:therapeutic use*; D051381:Rats; D013618:Tachyphylaxis
D010618:Phenanthrolines; D004205:Cromolyn Sodium